AI
| Followers | 70 |
| Posts | 8978 |
| Boards Moderated | 0 |
| Alias Born | 03/06/2016 |
Thursday, June 24, 2021 4:23:33 PM
"Anavex 2-73 currently holds fast track designation, rare pediatric disease designation, and orphan drug designation from the FDA for the treatment of Rett syndrome."
Having all three (coupled with clinically meaningful and statistically significant
